Repurposing of Drugs Targeting YAP-TEAD Functions
Drug repurposing is a fast and consolidated approach for the research of new active compounds bypassing the long streamline of the drug discovery process. Several drugs in clinical practice have been reported for modulating the major Hippo pathway’s terminal effectors, namely YAP (Yes1-ass...
Main Authors: | Gian Marco Elisi, Matteo Santucci, Domenico D’Arca, Angela Lauriola, Gaetano Marverti, Lorena Losi, Laura Scalvini, Maria Laura Bolognesi, Marco Mor, Maria Paola Costi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/10/9/329 |
Similar Items
-
Identification of a Quinone Derivative as a YAP/TEAD Activity Modulator from a Repurposing Library
by: Angela Lauriola, et al.
Published: (2022-02-01) -
Protein-Protein Interaction Disruptors of the YAP/TAZ-TEAD Transcriptional Complex
by: Ajaybabu V. Pobbati, et al.
Published: (2020-12-01) -
Leveraging Hot Spots of TEAD–Coregulator Interactions in the Design of Direct Small Molecule Protein-Protein Interaction Disruptors Targeting Hippo Pathway Signaling
by: Bin Zhao, et al.
Published: (2023-04-01) -
Targeting the Hippo Pathway and Cancer through the TEAD Family of Transcription Factors
by: Jeffrey K. Holden, et al.
Published: (2018-03-01) -
The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment
by: Reza Bayat Mokhtari, et al.
Published: (2023-07-01)